Da An Gene Co Ltd of Sun Yat-Sen University (SHE:002030) — Stock Price
Da An Gene Co Ltd of Sun Yat-Sen University (SHE:002030) is currently trading at CN¥5.65 CNY, up 0.71% today. Over the past 52 weeks, shares have ranged between CN¥4.88 and CN¥7.71. This page tracks Da An Gene Co Ltd of Sun Yat-Sen University's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Da An Gene Co Ltd of Sun Yat-Sen Univers worth.
Da An Gene Co Ltd of Sun Yat-Sen University (002030) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Da An Gene Co Ltd of Sun Yat-Sen University's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Da An Gene Co Ltd of Sun Yat-Sen University Income Statement — Revenue, Profit & Earnings by Year
Da An Gene Co Ltd of Sun Yat-Sen University's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥757.66 Million | CN¥853.02 Million | CN¥1.18 Billion | CN¥12.05 Billion | CN¥7.66 Billion |
| Cost of Revenue | CN¥512.17 Million | CN¥629.58 Million | CN¥801.12 Million | CN¥3.62 Billion | CN¥1.96 Billion |
| Gross Profit | CN¥245.49 Million | CN¥223.44 Million | CN¥379.78 Million | CN¥8.43 Billion | CN¥5.70 Billion |
| Research & Development | CN¥186.34 Million | CN¥336.24 Million | CN¥302.33 Million | CN¥702.40 Million | CN¥508.80 Million |
| SG&A | CN¥102.05 Million | CN¥125.19 Million | CN¥127.85 Million | CN¥306.88 Million | CN¥333.39 Million |
| Total Operating Expenses | CN¥1.05 Billion | CN¥1.29 Billion | CN¥258.15 Million | CN¥2.10 Billion | CN¥1.58 Billion |
| Operating Income | CN¥-297.16 Million | CN¥-1.07 Billion | CN¥121.62 Million | CN¥6.33 Billion | CN¥4.13 Billion |
| EBITDA | — | CN¥-374.26 Million | CN¥-11.82 Million | CN¥6.35 Billion | CN¥4.09 Billion |
| EBIT | — | CN¥-713.02 Million | CN¥-356.04 Million | CN¥6.08 Billion | CN¥3.90 Billion |
| Interest Expense | CN¥4.19 Million | CN¥9.74 Million | CN¥10.63 Million | CN¥14.37 Million | CN¥14.90 Million |
| Income Before Tax | CN¥-756.99 Million | CN¥-1.07 Billion | CN¥113.54 Million | CN¥6.32 Billion | CN¥4.12 Billion |
| Income Tax Expense | — | CN¥-132.05 Million | CN¥41.80 Million | CN¥891.38 Million | CN¥501.59 Million |
| Net Income | CN¥-744.38 Million | CN¥-925.17 Million | CN¥104.66 Million | CN¥5.41 Billion | CN¥3.62 Billion |
Da An Gene Co Ltd of Sun Yat-Sen University Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Da An Gene Co Ltd of Sun Yat-Sen University's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥8.51 Billion | CN¥9.58 Billion | CN¥11.02 Billion | CN¥14.76 Billion | CN¥10.34 Billion |
| Total Current Assets | CN¥2.84 Billion | CN¥3.78 Billion | CN¥5.31 Billion | CN¥8.77 Billion | CN¥5.98 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥593.89 Million | CN¥63.00 Million | CN¥1.40 Billion | CN¥480.90 Million | CN¥380.01 Million |
| Net Receivables | CN¥745.54 Million | CN¥1.30 Billion | CN¥2.17 Billion | CN¥4.19 Billion | CN¥2.34 Billion |
| Inventory | CN¥147.58 Million | CN¥198.21 Million | CN¥239.52 Million | CN¥369.60 Million | CN¥493.72 Million |
| Property, Plant & Equipment | — | — | — | — | CN¥863.06 Million |
| Goodwill | CN¥0.00 | CN¥0.00 | CN¥0.00 | CN¥0.00 | CN¥0.00 |
| Total Liabilities | CN¥1.15 Billion | CN¥1.43 Billion | CN¥1.86 Billion | CN¥3.14 Billion | CN¥2.68 Billion |
| Total Current Liabilities | CN¥1.01 Billion | CN¥1.29 Billion | CN¥1.72 Billion | CN¥2.97 Billion | CN¥2.52 Billion |
| Long-term Debt | CN¥0.00 | CN¥0.00 | CN¥0.00 | CN¥0.00 | CN¥0.00 |
| Net Debt | — | CN¥-715.10 Million | CN¥-646.75 Million | CN¥-2.37 Billion | CN¥-1.81 Billion |
| Total Stockholder Equity | CN¥7.14 Billion | CN¥7.88 Billion | CN¥8.88 Billion | CN¥11.30 Billion | CN¥7.35 Billion |
| Retained Earnings | CN¥3.87 Billion | CN¥4.61 Billion | CN¥5.56 Billion | CN¥7.93 Billion | CN¥4.62 Billion |
Da An Gene Co Ltd of Sun Yat-Sen University Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Da An Gene Co Ltd of Sun Yat-Sen University generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥319.49 Million | CN¥300.33 Million | CN¥845.76 Million | CN¥4.15 Billion | CN¥3.30 Billion |
| Capital Expenditures | CN¥239.00 Million | CN¥174.41 Million | CN¥572.77 Million | CN¥1.50 Billion | CN¥658.75 Million |
| Free Cash Flow | CN¥80.49 Million | CN¥125.92 Million | CN¥207.34 Million | CN¥2.65 Billion | CN¥2.65 Billion |
| Investing Cash Flow | — | CN¥-217.39 Million | CN¥-129.34 Million | CN¥-1.96 Billion | CN¥-1.38 Billion |
| Financing Cash Flow | — | CN¥-205.96 Million | CN¥-2.32 Billion | CN¥-1.79 Billion | CN¥-626.55 Million |
| Dividends Paid | CN¥-8.46 Million | CN¥27.88 Million | CN¥2.46 Billion | CN¥1.56 Billion | CN¥482.43 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥299.67 Million | CN¥350.36 Million | CN¥365.28 Million | CN¥298.44 Million | CN¥192.02 Million |
| Change in Cash | CN¥-363.71 Million | CN¥-121.90 Million | CN¥-1.60 Billion | CN¥427.93 Million | CN¥1.30 Billion |
Da An Gene Co Ltd of Sun Yat-Sen University Earnings History — EPS Actual vs. Analyst Estimates
Track Da An Gene Co Ltd of Sun Yat-Sen University's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 29, 2026 | -0.07 | — | — |
| Oct 31, 2025 | 0.03 | — | — |
| Aug 30, 2025 | -0.17 | — | — |
| Apr 29, 2025 | 0.04 | — | — |
| Mar 29, 2025 | -0.30 | — | — |
| Oct 30, 2024 | -0.07 | — | — |
| Aug 31, 2024 | -0.03 | — | — |
| Apr 29, 2024 | -0.26 | — | — |